Company: EUDAW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001493152-25-011729
Chunk: 22

Company: EUDA Health Holdings Ltd
Filing Date: 2025-08-08
Form: 424B5
Chunk 22
---
, undergoes a Fundamental Transaction, as defined in the Convertible Note, the Investor may, upon conversion of the Convertible Notes, choose to receive the same consideration as the Company’s shareholders. The conversion price will be adjusted. If the Company is not the surviving entity, the successor must assume the Company’s obligations under the Convertible Note and provide a similar security, maintaining the holder’s economic value.

Governing Law

The Convertible Note is governed by, and construed in accordance with, the laws of the State of New York.

Description of Ordinary Shares

The material terms and provisions of our Ordinary Shares are described under the caption “Description of Securities” beginning on page 9 of the accompanying base prospectus.

We are authorized to issue 5,000,000 ordinary shares and NIL preferred shares with no par value each.

As of the date of this prospectus supplement, there were 37,156,382 ordinary shares and no shares of our preferred shares outstanding.

| S-15 |

<div align='center'>CAPITALIZATION</div>

The following table sets forth our capitalization as of December 31, 2024:

|                                                                                                                   |     | As                   
 of December 31, 2024 |             |   |     |             |            |   |     |                   |             |   |
|:------------------------------------------------------------------------------------------------------------------|:----|:---------------------|------------:|:--|:----|:------------|-----------:|:--|:----|:------------------|------------:|:--|
|                                                                                                                   |     | Actual               |             |   |     | As          
 Adjusted    
 (unaudited) |            |   |     | Pro               
 forma as Adjusted 
 (unaudited)       |             |   |
| Shareholders’ Equity                                                                                              |     |                      |             |   |     |             |            |   |     |                   |             |   |
| Ordinary shares, unlimited authorized,                                                                            
 37,153,049 shares issued and outstanding, actual and 41,305,760 shares issued and outstanding, pro forma adjusted |     |                      |  47,806,899 |   |     |             | 10,000,000 |   |     |                   |  57,806,899 |   |
| Accumulated deficit                                                                                               |     |                      | (50,100,426 | ) |     |             | (2,552,500 | ) |     |                   | (52,